Search Orphan Drug Designations and Approvals
-
Generic Name: | verteporfin |
---|---|
Date Designated: | 03/09/2012 |
Orphan Designation: | Treatment of chronic or recurrent central serous chorioretinopathy |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Valeant Pharmaceuticals North America LLC 700 Route 202/206 North Bridgewater, New Jersey 08807 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-